New York, NY, United States of America

Shakeel Modak


 

Average Co-Inventor Count = 1.5

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Shakeel Modak in Cancer Treatment

Introduction

Shakeel Modak is a prominent inventor based in New York, NY, specializing in innovative methods for treating cancer. He has been instrumental in developing therapies that enhance the effectiveness of cancer treatments, particularly neuroblastoma. With a total of two patents to his name, Modak's contributions to the field of oncology are noteworthy.

Latest Patents

Modak's latest patents include significant advancements in cancer treatment methodologies. The first patent focuses on "Methods for treating neuroblastoma with combination therapy." This patent outlines methods that utilize an anti-GD2 antibody, at least one chemotherapeutic agent, and at least one hematopoietic growth factor to treat neuroblastoma. Additionally, it provides compositions specifically designed for this purpose. The second patent is titled "Methods of enhancing immunogenicity of poorly immunogenic antigen-specific vaccines using oral yeast beta-glucans." This patent presents methods for improving the immunogenicity of vaccines that are typically poorly immunogenic. It also discusses promoting the diversification of the gut microbiome in subjects by administering an effective amount of a beta-glucan extract derived from yeast.

Career Highlights

Shakeel Modak is affiliated with the Memorial Sloan Kettering Cancer Center, where he continues to work on groundbreaking cancer research. His role at this prestigious institution allows him to collaborate with leading experts in the field and contribute to significant advancements in cancer therapies.

Collaborations

Some of his notable coworkers include Nai-Kong V Cheung and Govind Ragupathi, who are also recognized for their contributions to cancer research and treatment.

Conclusion

Shakeel Modak's innovative work in cancer treatment, particularly in neuroblastoma, showcases his commitment to improving patient outcomes through advanced therapies. His patents reflect a deep understanding of the complexities of cancer treatment and the potential for new therapeutic approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…